ORTEXORTEX News
Tracking HWC? Get live short interest, options flow, and signals on ORTEX.Sign up free →
HW
Trader NoteHWC

HWC Earnings Land, Shorts Digest the Result

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 21 Oct 2026, 18:29

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Hancock Whitney reported after the close on October 20, and the question now is whether the short interest built into that print begins to unwind or holds its ground.

The Q3 earnings print arrived with short interest at 7.84% of the free float, up 22% over the past month and 3.8% on the week. That build, flagged in the pre-earnings note, was the dominant positioning story heading into the release. One day after the print, the short position dipped just 1.1%, to roughly 6.56 million shares. That is not a meaningful unwind. It suggests bears are not rushing for the exits, even after the stock gained 2.2% on the day and 2.8% on the week, closing at $74.13. The borrow market itself remains unthreatening: availability is at 656%, well above the 52-week low of 365%, and the cost to borrow has eased to 0.40%, down 17% over the past month. There is no mechanical squeeze pressure here. Short sellers can hold cheaply, and plenty of shares remain available to borrow.

Options positioning had been leaning bullish into the print and stays there. The put/call ratio of 0.26 is marginally below its 20-day average of 0.28, roughly 1.3 standard deviations on the call-heavy side. That tilt has been consistent across October, suggesting the options market read the earnings setup more constructively than the short sellers did. With the event now behind the stock, the question is whether this call skew fades or persists.

The Street is broadly constructive but not uniformly so, and today's analyst moves reflect that split. Piper Sandler, maintaining its Overweight, raised its target to $88 from $87 on earnings day. Keefe, Bruyette and Woods held its Market Perform rating and trimmed its target modestly to $79 from $80. The mean price target across the Street is $84.73, implying roughly 14% upside from the current price. The bull case centres on the One Florida Bank acquisition: the $378 million cash deal adds $1.7 billion in loans and $1.9 billion in deposits, is expected to be accretive, and points toward a 2027 ROTCE of around 16.2%, alongside a CET1 ratio of 13.2% and Q2 EPS of $1.55 in line with consensus. Bears focus on credit: criticized commercial loans at 2.6% of total loans, a slipped allowance ratio of 1.42%, and concentrated exposure to healthcare, retail trade, and hospitality. M&A dilution risk adds to that list, with the Orlando deal implying roughly 7% TBVPS dilution. On valuation, the PE is 10.4x and price-to-book is 1.22x, both modest for a bank posting this earnings trajectory. The forward EPS growth factor ranks in the 91st percentile, and the dividend score lands in the 92nd, though the EPS surprise rank is a lower 40th.

FDIC call report data from the ORTEX Alt Data layer adds one factual note to the fundamental picture. Total deposits reached a record for any Q2 period in the dataset's history, at $29.9 billion as of the April 2026 quarter. Net loans and leases have now risen for five consecutive quarters, reaching $24.3 billion. The FDIC dataset has not yet been tested for whether it leads Hancock Whitney's reported figures, so no directional signal can be drawn from it. But the streak in loan growth is consistent with management's own narrative around balance sheet expansion.

Institutional ownership gives a picture of a well-held name. BlackRock reported 13.6% as of September 30, adding roughly 520,000 shares in the period. FMR, Dimensional, State Street, and both Vanguard entities each hold above 5%. None of the 13D/G filings on the register indicate activist intent. The short-term insider signal leans negative: the CFO sold $1.7 million in July and the Chief Banking Officer sold $381,000 in August, both discretionary and not under 10b5-1 plans. September transactions were small director grants, not open-market purchases.

With the earnings event now cleared, the focus shifts to whether short sellers at 7.84% of float begin to reduce positions given the stock's post-print resilience, or whether credit concerns flagged by the bears keep the position sticky through the next quarter.

Stocks in this article

See the live data behind this article on ORTEX.

Open HWC on ORTEX →

How this article was generated

Generated
21 Oct 2026, 18:30
Data as of
21 Oct 2026, 18:29
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.